Ketamine for Treatment-Resistant Depression
Mustansiriya Medical Journal July 1, 2021 Raad Saady Madhloom
Major depressive disorder (MDD) is of influence on about 350 million individuals worldwide, which is causing disability consecution and damaging consequences to the affected community and individuals. Treatments as antidepressant are affecting the system of monoamine where symptoms of depressive were relived in about 50% of cases. Such ratio turns into obviously low in depressed persons who...